Literature DB >> 31120750

Characterization of Structural Iron in Smectites - An Ab Initio Based X-ray Absorption Spectroscopy Study.

Annamária Kéri1,2, Rainer Dähn1, Matthias Krack3, Sergey V Churakov1,2.   

Abstract

Fe-bearing clay minerals are abundant in argillaceous rocks as their redox-active structural iron may control the sorption mechanism of redox sensitive elements on the surface of clay minerals. The extent and efficiency of the redox reactions depend on the oxidation state (Fe2+/Fe3+ ratio) and structural distribution of the substituting cations in the TOT-layer of clay minerals. Even smectites with similar structure originating from different locations might have a distinct arrangement of isomorphic substitutions (e.g., individual iron or Fe-Fe pairs). In this study, the proportion of different iron distribution in Milos-, Wyoming-, and Texas-montmorillonite was determined by combining X-ray absorption spectroscopy (XAS) with ab initio calculations. The relaxed atomic structures of the smectite models with different arrangement of individual Fe atoms and Fe-Fe/Fe-Mg clusters served as the basis for the calculations of the XAS spectra. The combination of simulation results and measured Fe K-edge XAS spectra of Wyoming-, Milos- and Texas-montmorillonites suggested that iron is present as Fe3+ in the octahedral sheet. Fe3+ in Texas-montmorillonite has a tendency to form clusters, while no definitive statement about clustering or avoidance of Fe-Fe and Fe-Mg pairs can be made for Milos- and Wyoming-montmorillonite.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31120750     DOI: 10.1021/acs.est.8b06952

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  1 in total

1.  Structural Evolution of Ag-LEV Zeolite upon Heating: An In Situ Single-Crystal X-ray Diffraction (SC-XRD) and X-ray Absorption Spectroscopy (XAS) Study.

Authors:  Georgia Cametti; Andreas C Scheinost; Sergey V Churakov
Journal:  ACS Omega       Date:  2020-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.